The publisher has released its latest report “Israel Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
The Israeli healthcare market is one of the major emerging markets in the Middle East, with a strong focus on health technology, research & development (R&D), and the advancement of medical infrastructure. Israel’s pharmaceutical market was worth $2.1 billion in 2014, which increased at a Compound Annual Growth Rate (CAGR) of 3.4% to $2.4 billion in 2018 in terms of US dollars. The market value is expected to grow further and is forecast to reach $3.2 billion by 2027. Israel is a powerhouse of medical innovation. Israel’s medical devices market was valued at $1.1 billion in 2015, which increased to $1.6 billion in 2021 at a CAGR of 7.1%. The medical device market is expected to grow at a CAGR of 2.7% from $1.5 billion in 2022 to $1.8 billion in 2028. Here, 65% of the medical device market is import-driven. The top import medical devices are surgical instruments and other medical electronics, lab reagents, diagnostic equipment, and catheters. In January 2021, Ayalon Highways Corporation, the Civil Aviation Authority of Israel (CAAI), and the Israeli Ministry of Transportation, among others collaboratively launched the NAAMA Initiative (Israel Urban Air Mobility Initiative, a Hebrew acronym for city air transport) intending to establish a national drone delivery network to revolutionize and establish a faster and safer medical supply channel in the upcoming years.
The report provides information on the healthcare, regulatory, and reimbursement landscape in Israel, and includes:
This report will enhance your decision-making capability by allowing you to:
The Israeli healthcare market is one of the major emerging markets in the Middle East, with a strong focus on health technology, research & development (R&D), and the advancement of medical infrastructure. Israel’s pharmaceutical market was worth $2.1 billion in 2014, which increased at a Compound Annual Growth Rate (CAGR) of 3.4% to $2.4 billion in 2018 in terms of US dollars. The market value is expected to grow further and is forecast to reach $3.2 billion by 2027. Israel is a powerhouse of medical innovation. Israel’s medical devices market was valued at $1.1 billion in 2015, which increased to $1.6 billion in 2021 at a CAGR of 7.1%. The medical device market is expected to grow at a CAGR of 2.7% from $1.5 billion in 2022 to $1.8 billion in 2028. Here, 65% of the medical device market is import-driven. The top import medical devices are surgical instruments and other medical electronics, lab reagents, diagnostic equipment, and catheters. In January 2021, Ayalon Highways Corporation, the Civil Aviation Authority of Israel (CAAI), and the Israeli Ministry of Transportation, among others collaboratively launched the NAAMA Initiative (Israel Urban Air Mobility Initiative, a Hebrew acronym for city air transport) intending to establish a national drone delivery network to revolutionize and establish a faster and safer medical supply channel in the upcoming years.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Israel, and includes:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Bayer, Merck, GlaxoSmithKline (GSK), Teva Pharmaceuticals, and Kamada.
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, GE Healthcare, Bioview, Zimmer Biomet, Coloplast, and SHL Telemedicine.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the Israeli healthcare market.
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving the Israeli healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Israeli healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
1. Table of Contents
2. Executive Summary
3. Overview of Pharmaceutical Market
4. Overview of Medical Devices Market
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
6. Deal Analysis
7. Healthtech Landscape
13 Appendix
List of Tables
List of Figures
